Privia Health terminates $65M SVB credit facility; no borrowings outstanding

Privia Health Group, Inc.

Terminated $65M Revolving Loan Facility with SVB on March 16, 2023.
No borrowings or letters of credit outstanding under the facility.
No early termination penalties incurred.
Company states no near-term credit needs given current cash balance.
Evaluating future credit facility needs with other financial institutions.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Privia Health Group, Inc. terminated Credit Agreement with SVB, as administrative agent, collateral agent and lender valued at $65 million (effective 2023-03-16).

Action: termination
Agreement: credit facility
Counterparty: SVB, as administrative agent, collateral agent and lender
Value: $65 million
Effective: 2023-03-16

Exact text from the filing

On March 16, 2023, Privia Health Group, Inc. (the “Company”) provided notice to terminate the Credit Agreement, dated as of November 15, 2019, as amended by the Third Amendment, dated as of August 27, 2021 (as amended, the “Credit Agreement”), by and among the Company, certain of the Company’s subsidiaries, as guarantors, and SVB, as administrative agent, collateral agent and lender, providing for revolving loans in an amount up to $65 million, including a letter of credit sub-facility of $5 million (the “Revolving Loan Facility”).

View on SEC.gov

Browse all material agreements →

Privia Health Group, Inc. filing history →

Source: SEC EDGAR

accession 0001759655-23-000043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.